Full text:
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic ResonanceNeed to perform:
"Athletes with AR should be evaluated annually to determine whether sports participation can continue."
(Class I Recommendation; Level of Evidence C)
"Exercise testing to at least the level of activity achieved in competition and the training regimen is helpful in confirming asymptomatic status in athletes with AR and assessing blood pressure responses."
(Class I Recommendation; Level of Evidence C)
Mild-Mod AR, normal LVEF, no/mild LV dilatation, normal exercise test
"Athletes with mild to moderate degrees of AR (stage B) with normal LV ejection fraction and no or mild LV dilatation can participate in all competitive sports if they have normal exercise tolerance on exercise testing."
(Class I Recommendation;
Level of Evidence C)
Mild-mod AR, normal LVEF, mod LV dilatation
"Athletes with mild to moderate degrees of AR with normal LV ejection fraction and moderate LV dilatation (LVESD < 50 mm [men], < 40 mm [women], or < 25 mm/m2 [either sex]) can reasonably participate in all competitive sports if they have normal exercise tolerance on exercise testing."
(Class IIa Recommendation;
Level of Evidence C)
Severe AR, LVEF ≥50%, LVESD < parameters below, normal exercise, no progession of AR severity, no progression of LV dilatation
"It may be reasonable for athletes with severe AR, LV ejection fraction ≥50% (stage C1), and LVESD < 50 mm (men), < 40 mm (women), or < 25 mm/m2 (either sex) to participate in all competitive sports if they have normal exercise tolerance, and Doppler echocardiography indicates no progression of AR severity or severity of LV dilatation."
(Class IIb Recommendation; Level of Evidence C)
Severe AR, symptoms, LVEF < 50%, large LVESD or increase in LVEDD
"Athletes with severe AR and symptoms (stage D), LV systolic dysfunction with ejection fraction < 50% (stage C2), LVESD >50 mm or >25 mm/m2 (stage C2), or severe increase in LVEDD (>70 mm or ≥35.3 mm/m2 [men], >65 mm or ≥40.8 mm/m2 [women]) should not participate in competitive sports."
(Class III Recommendation; Level of Evidence C)
Aortic dimensions 41-45mm
"It may be reasonable for athletes with AR and aortic dimensions of 41 to 45 mm to participate in sports with low risk of bodily contact."
(Class IIb Recommendation; Level of Evidence C)
Full text:
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance
Reference: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease.
A Scientific Statement From the AHA and ACC. Circulation 2015
Disclaimer: This website is derived from published guidelines, but does not constitute medical advice nor does it replace clinical judgement. Only the text in quotation marks are direct quotations from the original guidelines. Text not in quotations as well as the method of information display are all that of the website creator and are not part of the original published guidelines. Please consult a physician to discuss any patient-specific matters.
Key: AR = aortic regurgitation, LVEDD = left ventricle end diastolic diameter, LVESD = left ventricle end systolic diameter